Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab (OCTAVE)

Authors
Publication date
1 May 2019
Publisher
Providence St. Joseph Health Digital Commons

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Providence St. Joseph Health Digital Commons

    redirect
    oaioai:digitalcommons.providence....
    Last time updated on 17/10/2023